In the News

Poluru Reddy and Anup Madan discuss the vital role laboratory-developed tests often play in drug development and clinical trials.

The authors discuss the powerful technology that flow cytometry offers the emerging cell and gene therapies field.

This article presents the use of charged aerosol detection combined with LC/UV-MS to obtain a more complete E&L profile.

PPD clinical research business experts comment on how the COVID-19 pandemic has accelerated the trend toward home diagnostics and raised the bar for faster, more detailed test results.

The authors discuss how inclusion of scientific surveillance techniques as part of centralized monitoring enhances the ability to monitor critical and non-critical data.

The authors explore the advancement of CAR-T therapies in China. While initial strides were primarily being made in the U.S. markets, can both foreign and domestic players win in China’s CGT market?

Susan Oliveria discusses how and why RWD and RWE are making an important impact on the development of medicines.

The authors examine how a new generation of extraction, identification and quantification tools – now recognized as approved methods by regulatory bodies – is changing the E&L testing landscape.

Michael Cohen comments on how digitizing, decentralizing and near-patient can reduce the environmental impact of clinical research.